Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunovant, Inc. - Common Stock (NQ:IMVT)

34.12 +3.59 (+11.76%)
Delayed Quote Updated: 2:06 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunovant, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-... 
Via Benzinga
News headline image
Why Shares of Immunovant Are Tanking Today ↗
Shareholders are throwing in the towel after not getting the deal they were expecting. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Gains 50 Points; Marin Software Shares Plummet ↗
Toward the end of trading Monday, the Dow traded up 0.02% to 34,941.69 while the NASDAQ rose 0.37% to 14,727.42. The S&P also rose, gaining 0.10% to 4,399.45. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Immunovant Stock Plunges After Credit Suisse Downgrade Citing Unclear Catalysts ↗
Credit Suisse downgraded Immunovant Inc (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1... 
Via Benzinga
News headline image
Mid-Day Market Update: Crude Oil Down 2.5%; Exicure Shares Spike Higher ↗
Midway through trading Monday, the Dow traded up 0.35% to 35,058.26 while the NASDAQ rose 0.52% to 14,748.83. The S&P also rose, gaining 0.39% to 4,412.29. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
40 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Higher; Global Payments Posts Upbeat Q2 Earnings ↗
Following the market opening Monday, the Dow traded up 0.58% to 35,138.90 while the NASDAQ rose 0.40% to 14,731.03. The S&P also rose, gaining 0.46% to 4,415.36. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week... 
Via Benzinga
News headline image
Immunovant Stock Plunges On $200M Equity Investment From Roivant To Support IMVT-1401 Development ↗
Immunovant Inc (NASDAQ: IMVT) has received a $200 million strategic investment from Roivant Sciences that the Company will use to advance IMVT-1401 in... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Exicure (NASDAQ:XCUR) stock moved upwards by 35.55% to $1.83 during Monday's pre-market session. The company's market cap stands at $161.0 million.... 
Via Benzinga
News headline image
Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to... 
Via Talk Markets
News headline image
Biotech Losers In 2021 That Could Bounce Big In The Second Half ↗
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Citigroup cut the price target for AutoZone, Inc. (NYSE: AZO) from $1,700 to $1,636. AutoZone shares rose 0.3% to close at $1,410.85 on Tuesday. Barclays raised the price target... 
Via Benzinga
News headline image
68 Biggest Movers From Yesterday ↗
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Rises 90 Points; Cloudera Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded up 0.26% to 34,620 while the NASDAQ rose 0.13% to 13,766.75. The S&P also rose, gaining 0.09% to 4,207.71. The U.S... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Nuwellis (NASDAQ:NUWE) stock incr... 
Via Benzinga
News headline image
Mid-Day Market Update: Crude Oil Surges 3.5%; Immunovant Shares Plummet ↗
Midway through trading Tuesday, the Dow traded up 0.35% to 34,651.75 while the NASDAQ fell 0.31% to 13,705.51. The S&P also rose, gaining 0.04% to 4,205.97. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
36 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares jumped 67.3% to $5.94 after the company announced its subsidiary, Gibson Technical Services, reached an agreement with TEC... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mixed; ISM Manufacturing PMI Rises to 61.2 In May ↗
Following the market opening Tuesday, the Dow traded up 0.28% to 34,625.27 while the NASDAQ fell 0.23% to 13,717.52. The S&P also rose, gaining 0.06% to 4,206.76. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET on Tuesday, 4 companies set new 52-week lows. Intriguing Points: Immunovant (NASDAQ:IMVT) was the largest firm by market cap to set a new 52-week... 
Via Benzinga
News headline image
NASDAQ:IMVT Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Immunovant, Inc. ↗
San Diego, CA -- (SBWIRE) -- 05/19/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Immunovant, Inc. 
Via SBWire
Topics Lawsuit
News headline image
'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines ↗
Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs. Here is a look back at the week in SPACs for... 
Via Benzinga
News headline image
Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company ↗
A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal:... 
Via Benzinga
News headline image
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.